MedPath

Evaluation the effect of probiotic on drug-resistant epilepsy

Phase 2
Recruiting
Conditions
Drug resistant epilepsy.
Epilepsy and recurrent seizure
Registration Number
IRCT20170615034549N2
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with a diagnosis of refractory epilepsy.
Patients are between 3 and 15 years old.
children who have a medical record with a medical doctor and have been referred to the pediatric neurosurgery clinic of Shahid Beheshti Hospital for treatment.
They have had at least one seizure in the past three months.

Exclusion Criteria

Children that the cause of their seizures are secondary such as electrolyte imbalances
Children with underlying, genetic or progressive brain diseases.
Children who have had probiotic use for one month before the study.
Children who take antibiotics with any reason for one month before the study.
Children who take any immunosuppressant medication with any reason for one month before the study.
Children who take any vitamin or mineral supplement except vitamin D

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizure frequency. Timepoint: before and after probiotic treatment. Method of measurement: asking frequency of seizure frequency.
Secondary Outcome Measures
NameTimeMethod
Blood indices(Sodium- calcium - potassium - magnesium - hepatic enzymes including alkaline phosphatase, AST and ALT- bilirubin - creatinin). Timepoint: before and after. Method of measurement: Measurement of venous blood sample.
© Copyright 2025. All Rights Reserved by MedPath